Inhibition of PARP activity by PJ34 sensitises NSCLC cells to cisplatin


Autoria(s): Barr, M.P.; Rausch, R.; Thomale, J.; Richard, D.; Cuffe, S.; Finn, S.; O'Byrne, K.J.
Data(s)

29/01/2014

Identificador

http://eprints.qut.edu.au/68171/

Publicador

Elsevier

Relação

DOI:10.1016/S0169-5002(14)70005-4

Barr, M.P., Rausch, R., Thomale, J., Richard, D., Cuffe, S., Finn, S., & O'Byrne, K.J. (2014) Inhibition of PARP activity by PJ34 sensitises NSCLC cells to cisplatin. In 12th Annual British Thoracic Oncology Group Conference, 29-31 January 2014, Dublin, Ireland.

Direitos

Copyright 2014 Elsevier Ireland Ltd.

Fonte

School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation

Tipo

Conference Item